Company intelligence / Profile preview

CEI

Brunswick, Maine, United States

Ownership: Private
Development stage: Other

Overview

CEI Ventures, Inc. is a community development venture capital firm based in Maine that invests in companies with the potential to deliver social and economic benefits, including in the life sciences space. It recently participated in a $25 million funding round for Galatea Bio, a biotechnology company leveraging AI and large-scale genomic data to advance ancestry-aware disease modeling, risk assessment, and precision medicine, with a focus on underserved populations[1]. CEI Ventures does not develop drugs or therapies itself but supports innovators in the sector.

Industry: Investors

Partnerships

Investment in Galatea Bio (as a limited partner in a funding round)

Beyond the preview

Go deeper on CEI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEI.

Explore the full profile